Stay updated on Ravulizumab Study in LN/IgAN Clinical Trial
Sign up to get notified when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.

Latest updates to the Ravulizumab Study in LN/IgAN Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.2 appears on the page, replacing v3.3.1; this is a minor site maintenance update and does not alter study details or how to use the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedPublications in PubMed section now include an explicit note that entries are automatically filled and may not be directly related to the study; the revision tag updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe funding-lapse notice is removed from the page. The study details and other information remain unchanged.SummaryDifference0.2%

- Check43 days agoChange DetectedTwo new update timestamps were added (2025-10-24 and 2025-10-27) and earlier timestamps (2025-10-21 and 2025-10-22) were removed on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check50 days agoChange DetectedStudy Record Dates now display 'Last Update Posted (Estimated)' instead of the previous 'Last Update Posted'; the old entry was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check57 days agoChange DetectedStatus and date updates indicate termination or negative efficacy, with new dates added and old status removed.SummaryDifference1%

Stay in the know with updates to Ravulizumab Study in LN/IgAN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.